Example: Heart Attack
Search clinical trials for: SYR-619
Total 1 results
-
NCT00763347Terminated
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Sponsors and Collaborators
- Assiut University
- Mayo Clinic
- Abrexa Pharmaceuticals, Inc.
- Ministry of Foreign Affairs, Luxembourg
- Novartis Pharmaceuticals
- Pfizer
- Assistance Publique - Hôpitaux de Paris
- Kelly Ann Schmidtke
- Robert Bosch Medical Center
- Revive Wellness Inc.
- National Cancer Institute (NCI)
- AstraZeneca
- Trabzon Kanuni Education and Research Hospital
- West Parry Sound Health Centre
- M.D. Anderson Cancer Center
- Mounzer Agha
- GlaxoSmithKline
- University College, London
- Cairo University
- Dr. Gerhard Pölzl
- View Full List
Medical Conditions
- Aluminium Overload
- Pain
- HIV Metabolic Syndromes
- Wound Cosmesis
- Stage IV Splenic Marginal Zone Lymphoma
- Veno Occlusive Disease, Hepatic
- Diabetic Polyneuropathies
- Coronary Artery Disease
- Prostate Cancer
- Ocular Ischemia Syndrome
- Patient-controlled Sedation
- Asthma
- Unexplained Recurrent Miscarriage and Recurrent Implantation Failure
- HIV Infections
- Stroke
- Breast Cancer
- Hypertension
- Variceal Rebleeding Rate and Infections
- Depression
- Obesity
- View Full List
Drug Interventions
- docetaxel
- Cyclophosphamide
- Fentanyl (Nasalfent, Fentanyl Citrate Nasal Spray)
- Carboxymethylcellulose Based Eye Drop Formulation A
- Prednisone
- Capecitabine
- Carboplatin
- 3% Diquafosol tetrasodium
- COVI-MSC
- Dexamethasone
- Copper Cu 64-DOTA B-Fab
- KW-6356 Y Dose
- JAB-3068
- Imatinib Mesylate 400 MG Oral Tablet
- Bevacizumab
- Paclitaxel
- Intra-arterial administration of neuroprotective agents
- Cisplatin
- Gemcitabine
- JNJ-55308942 100 mg
- View Full List
CROs by country
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Croatia
- Contract Research Organizations in Egypt
- Contract Research Organizations in Gambia
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Panama
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Serbia
- Contract Research Organizations in South Korea
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Uzbekistan
- CRO list by country